Skip to main content

Report on Aging in Orange County 2022

By Commentary, In the News
Contributed by Orange County Aging Services Collaborative: We are excited to announce the release of the Report on Aging in Orange County 2022! This report maps the system of senior support and data available in four key areas: disability, the digital divide, food insecurity, and social isolation.Everyone is invited to read the report and are encouraged to share with your networks. Report on Older Adults in Orange County: 2022 Report on Aging in Orange County 2022
Read More

Hope Dies Last – Alzheimer’s: A Journey of Lost Memories

By Carousel Slider, Commentary, Community Events, In the News
Don't miss this upcoming documentary filmed by OCWorld, featuring Director Dr. Joshua Grill - Tune in this Sunday on KDOCTV at 3:30pm! Contributed by OCWorld: "Tune in THIS SUNDAY on KDOCTV at 3:30pm for the premier of our final installment of our first season. This is Hope Dies Last - Alzheimer's: A Journey of Lost Memories. This short documentary explores the impacts of Alzheimer's disease in Orange County, a growing epicenter for the disease. Featuring insights on the disease from experts like Dr. Joshua Grill from UCI MIND and Deborah Levy, Executive Director of the Alzheimer's Association OC Chapter.
Read More

Cell therapy: a new frontier in Parkinson’s disease

By Carousel Slider, Commentary, In the News
After decades of research into the causes and treatment of Parkinson's disease, UCI Health neurologist Dr. Claire Henchcliffe is hopeful that a new cell therapy can finally bring meaningful relief to patients with the progressive neurodegenerative movement disorder. A national expert on Parkinson's disease, she is one of a small group of U.S. researchers conducting a first-in-human clinical trial of transplanted stem cells engineered to replace dopamine-producing neurons that are destroyed by the debilitating and incurable condition. As the brain loses its ability to produce the potent neurotransmitting chemical, that leads to the tremors, stiffness, slowness and lack of coordination seen in Parkinson's patients. The…
Read More

Visit-to-Visit Blood Pressure Variability and CSF Alzheimer Disease Biomarkers in Cognitively Unimpaired and Mildly Impaired Older Adults

By Carousel Slider, Commentary, In the News
Blood pressure variability is an emerging risk factor for cognitive decline and dementia, but mechanisms remain unclear. The current study examined whether visit-to-visit blood pressure variability is related to CSF Alzheimer’s disease biomarker levels over time, and whether associations differed by APOE ϵ4 carrier status.
Read More

Join our team! Applications are now live for the Director of Scientific Communications

By Commentary
Join our team! Applications are now live for the Director of Scientific Communications. The University of California, Irvine’s Institute for Memory Impairments and Neurological Disorders (UCI MIND) has an opportunity for a Project Scientist. The mission of UCI MIND is to engage in cutting edge, interdisciplinary research designed to discover the basic mechanisms of neurodegeneration and brain aging, characterize the transition from normal aging to Alzheimer’s disease, and develop new treatments to slow or eliminate cognitive impairment resulting from any etiology. Critical to this mission are dissemination of research findings to the community for the purpose of increasing public confidence…
Read More

UCI Generates Preliminary Evidence of a Gene Mutation That May Reduce Risk of Alzheimer’s Disease

By Carousel Slider, Commentary, In the News
Image Courtesy: AARP Through new developments in Alzheimer’s research, UCI scientists have uncovered evidence of P522R, a particular gene mutation that may aid in minimizing the risk of developing Alzheimer’s disease. Alzheimer’s disease is a progressive disorder that slowly deteriorates memory and thinking skills in the brain, eventually leading to a loss in the ability to complete simple tasks such as  facilitating a conversation or responding to a stimulus in the environment. With the discovery of the disease in 1906 by Dr. Alois Alzheimer, its causes today are focused on two suspects: plaques and tangles in proteins. Beta-amyloid, fragments of…
Read More